Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry ; volume:05 ; number:02 ; year:2021 ; pages:e143-e151
TH open ; 05, Heft 02 (2021), e143-e151
- Contributor
-
Beyer-Westendorf, Jan
Marten, Sandra
Tittl, Luise
Naue, Christiane
Bornhäuser, Martin
- DOI
-
10.1055/s-0041-1728675
- URN
-
urn:nbn:de:101:1-2021061008160771271782
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beyer-Westendorf, Jan
- Marten, Sandra
- Tittl, Luise
- Naue, Christiane
- Bornhäuser, Martin
Other Objects (12)
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
Venous anomalies and thromboembolism
Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk
Venous Thromboembolism Issues in Women
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
Venous anomalies and thromboembolism
Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk
Venous Thromboembolism Issues in Women
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
Venous anomalies and thromboembolism
Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk